ADVFN ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Cytek Biosciences Inc

Cytek Biosciences Inc (CTKB)

4.59
0.20
(4.56%)
Cerrado 09 Julio 3:00PM
4.59
0.00
( 0.00% )
Pre Mercado: 6:00AM

Cytek Biosciences Inc (CTKB) Cotización

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
4.59
( - )
Postura de Compra
4.35
Postura de Venta
4.94
Volume Operado de la Acción
34
Volumen promedio (3 m)
US$ 1,326,197
Volumen financiero
-
0.00 Rango del Día 0.00
3.09 Rango de 52 semanas 6.18
Capitalización de Mercado [m]
Valor de Empresa
358.021M
Precio Anterior
4.59
Precio de Apertura
-
Última hora de negociación
05:54:03
Precio Promedio Ponderado
-
turnover
204.17M
Beneficio neto
-74M
Acciones en circulación
129,142,587
Flotante (%)
74.79%
Propiedad Institucional (%)
67.34%
Rendimiento del Dividendo (LTM)
Ratio Precio/Utilidad
-7.91
Precio/Ventas (P/V)
2.9
Beneficio por acción (BPA)
-0.58
Beta
1.17

Acerca de Cytek Biosciences Inc

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora C... Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitate scientific advances in biomedical research and clinical applications. The company offers Cytek aurora, northern lights systems, and Cytek aurora evo systems delivers cell analysis; Cytek Aurora CS System, a cellular complexity to perform additional downstream genomic and proteomic studies using phenotyping approaches; enhanced small particle detection; Cytek amnis imagestream imaging flow cytometers; Cytek guava muse cell analyzers; Cytek muse micro cell analyzers; Cytek guava easyCyte flow cytometers; and Cytek orion reagent cocktail preparation systems. It also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments. In addition, the company offers automated micro-sampling system and automated sample loader system, an automated loaders designed to integrate seamlessly into the Cytek aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for Cytek aurora, northern lights, and Cytek aurora evo systems; and customer support tools. Further, it provides conventional flow and image-based flow cytometry instrumentation and related products and services under the Amnis and Guava brand names. The company serves pharmaceutical and biopharma companies, academic research centers, and contract research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in Europe, Latin America, and the Middle East countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California. Mostrar más

Sector
Healthcare
Industria
Biotechnology & Life Sciences
Sitio web
Sede
Fremont, United States
Fundado
1992
Cytek Biosciences Inc is listed in the Healthcare sector of the NASDAQ with ticker CTKB. The last closing price for Cytek Biosciences was US$4.59. Over the last year, Cytek Biosciences shares have traded in a share price range of US$ 3.09 to US$ 6.18.

Cytek Biosciences currently has 129,142,587 shares in issue. The market capitalisation of Cytek Biosciences is US$592.76 million. Cytek Biosciences has a price to earnings ratio (PE ratio) of -7.91.

CTKB Últimas noticias

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.030.6578947368424.564.7354.319524984.5296524CS
40.5313.05418719214.064.7353.724152754.05557333CS
12-0.12-2.547770700644.714.993.3114323024.07474622CS
26-1.06-18.76106194695.655.993.3110602394.29628212CS
521.0529.66101694923.546.183.0910685184.36875616CS
156-3.86-45.68047337288.459.872.379098755.23951141CS
260-15.51-77.164179104520.128.72.378420117.68729087CS

CTKB - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Cytek Biosciences Inc?
El precio actual de las acciones de Cytek Biosciences Inc es US$ 4.59
¿Cuántas acciones de Cytek Biosciences Inc están en circulación?
Cytek Biosciences Inc tiene 129,142,587 acciones en circulación
¿Cuál es la capitalización de mercado de Cytek Biosciences Inc?
La capitalización de mercado de Cytek Biosciences Inc es USD 592.76M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Cytek Biosciences Inc?
Cytek Biosciences Inc ha negociado en un rango de US$ 3.09 a US$ 6.18 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Cytek Biosciences Inc?
El ratio precio/beneficio de Cytek Biosciences Inc es -7.91
¿Cuál es el ratio de efectivo a ventas de Cytek Biosciences Inc?
El ratio de efectivo a ventas de Cytek Biosciences Inc es 2.9
¿Cuál es la dirección registrada de Cytek Biosciences Inc?
La dirección registrada de Cytek Biosciences Inc es 47215 Lakeview Blvd, Fremont, California, 94538-6407
¿Cuál es la dirección del sitio web de Cytek Biosciences Inc?
La dirección del sitio web de Cytek Biosciences Inc es cytekbio.com
¿En qué sector industrial opera Cytek Biosciences Inc?
Cytek Biosciences Inc opera en el sector Biotechnology & Life Sciences

CTKB Operaciones

Más

Operaciones con retraso

Para obtener operaciones en tiempo real, actualice su cuenta

Actualizar a tiempo real
US Market News US Market News 3 minutos hace
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)July 10, 2026 7:01 AM
Business Wire Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to dev
DTIL
US Market News US Market News 4 minutos hace
PENSKE AUTOMOTIVE GROUP SCHEDULES SECOND QUARTER AND SIX MONTHS 2026 FINANCIAL RESULTS CONFERENCE CALLJuly 10, 2026 7:00 AM
PR Newswire (US) class="legendSpanClass"BLOOMFIELD HILLS, Mich., class="legendSpanClass"July 10, 2026 /PRNewswire
PAG
halbroke1 halbroke1 4 minutos hace
Fire_starter....Any Updates, Did Anyone Contact Management, When are We going to Rocket..I'm not Selling!!..
SEII
US Market News US Market News 4 minutos hace
Workforce Edge Named “Professional Development Solution Provider of the Year” in 2026 EdTech Breakthrough Awards ProgramJuly 10, 2026 7:02 AM
Business Wire Prestigious International Awards Program Recognizes Standout Educational Technology Companies and Visiona
STRA
Monksdream Monksdream 4 minutos hace
GMM. shaping for todays screamer
GMM
US Market News US Market News 4 minutos hace
VENU Featured in Forbes as a Model for the "Experience Per Dollar" EconomyJuly 10, 2026 7:03 AM
Business Wire Company's Luxe FireSuites® Ownership Model Cited Alongside Hudson Yards' Edge NYC in Analysis of Premium Consumer Trends
VENU
US Market News US Market News 4 minutos hace
Permian Resources Announces Second Quarter 2026 Earnings Conference CallJuly 10, 2026 7:05 AM
Business Wire Permian Resources Corporation (“Permian Resources” or the “Company”) (NYSE: PR) announced today that it will report second quarter 2026 financial and operating results af
PR
halbroke1 halbroke1 6 minutos hace
MLK $$$...ANY UPDATES, DID ANYONE CONTACT MANAGEMENT...WHEN ARE WE GOING TO ROCKET...IM NOT SELLING!!
SEII
ORCA ORCA 8 minutos hace
HOW LONG DO YOU THINK TILL THE JUDGE RULES??60 MILLION YEARS???INSIDERS SELL BECAUSE THEY MAKE 100% ON THEIR MONEY.BUY .005 AND SELL AT .01.EASY MONEY.I DID 5 CDs THIS YEAR,AND GOT 4% .AND WAS HAPPY.I CAN NOT IMAGINE HOW HAPPY I WOULD BE IF THAT WAS 100%.LOL.SO THEY SELL .01,AND REBUY DOUBLE THE SH
VPLM
reg2015 reg2015 8 minutos hace
great artical!!!! Someone should foward it to the FDA and to the POTUS. Peace Reg2015
NWBO
Monksdream Monksdream 10 minutos hace
GMM About

Global Mofy AI Ltd. is a holding company, which engages in AI-Driven technology solutions provider engaged in virtual content production, and digital assets development for the digital content industry. The firm utilizes its “Mofy Lab” technology platform, which consists of
GMM
Monksdream Monksdream 11 minutos hace
GMM, there it goes
GMM
Monksdream Monksdream 13 minutos hace
TOP 15 https://www.advfn.com/markets/nasdaq/premarket
funnytimes2 funnytimes2 14 minutos hace
Authority Magazine Features Kraig Biocraft Laboratories CEO Kim Thompson as an Industry Disruptor Reshaping the Future of Advanced Materials

Interview Highlights Thompson’s Entrepreneurial Vision and Kraig Labs’ Mission to Bring Spider Silk to Commercial Scale

ANN ARBOR
KBLB
Z06 MAN Z06 MAN 15 minutos hace
That’s old news..
KBLB
GetSeriousOK GetSeriousOK 16 minutos hace
When BIEL's 2026 annual financial statement reveals that Electrome only bought 25,000 units and is lying about having 100,000 units in stock, how will that make you feel about Electrome?

Electrome has a lot of little lies on their website, like their fake testimonials, the AI app that
BIEL
i_like_bb_stock i_like_bb_stock 17 minutos hace
Yes for sure and YYGH too let’s hope it goes CHOW as well
YYGH
hardlesson hardlesson 18 minutos hace
Ready for SCAG too. You nailed HAO and GMM. Pretty astonishing what they did last night and today with ZBAO and ELPW. JLHL to 30.00! Nuts, like a merry-go-round. :)
ELPW GMM HAO
cashclan cashclan 18 minutos hace
Hilarious already this AM


$2000 premarket ask...

Makes me thing NOT ENOUGH shares or just enough ...
EZES
mauiguy2 mauiguy2 19 minutos hace
BDN, LuLa gave me the answer I was looking for.......the pre-RS price in 2010 was .0004.

I might be wrong, but I don't think many companies do an RS when the price is so close to .0001 as CYBL did in 2010.
CYBL
sharkey1 sharkey1 19 minutos hace
OK. THX,
ELTP
ITYS ITYS 21 minutos hace
Bill, I believe BKTH is merely setting the table as they complete OEM test protocols and if you google or ask any AI about the recent XOSTS, anyone can identify that BKTH does have unique coatings as PFAS free is the next generation everyone is trying to achieve...thats my view.

Its m
BKTH

Su Consulta Reciente

Delayed Upgrade Clock